(Q34108091)

31 July 2017

Bactericidal activity of increasing daily and weekly doses of moxifloxacin in murine tuberculosis (English)

1 reference

31 July 2017

0 references

1 reference

5

William Bishai

1 reference

31 July 2017

4

Richard Chaisson

1 reference

31 July 2017

6

Jacques Grosset

1 reference

31 July 2017

2

Eric Nuermberger

1 reference

31 July 2017

Tetsuyuki Yoshimatsu

1

1 reference

PubMed ID

12019103

31 July 2017

Sandeep Tyagi

series ordinal

3

1 reference

PubMed ID

12019103

31 July 2017

language of work or name

English

0 references

publication date

1 June 2002

1 reference

Antimicrobial Agents and Chemotherapy

31 July 2017

1 reference

31 July 2017

46

1 reference

31 July 2017

6

1 reference

31 July 2017

1875-1879

1 reference

Serial counts of Mycobacterium tuberculosis in sputum as surrogate markers of the sterilising activity of rifampicin and pyrazinamide in treating pulmonary tuberculosis

31 July 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=127203

Effectiveness of once-weekly rifapentine and moxifloxacin regimens against Mycobacterium tuberculosis in mice

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=127203

The need for new drugs against tuberculosis. Obstacles, opportunities, and next steps

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=127203

Comparative pharmacokinetics of ciprofloxacin, gatifloxacin, grepafloxacin, levofloxacin, trovafloxacin, and moxifloxacin after single oral administration in healthy volunteers

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=127203

Pharmacokinetics of a once-daily oral dose of moxifloxacin (Bay 12-8039), a new enantiomerically pure 8-methoxy quinolone

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=127203

Pharmacokinetics and inflammatory-fluid penetration of moxifloxacin following oral or intravenous administration

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=127203

Moxifloxacin (BAY12-8039), a new 8-methoxyquinolone, is active in a mouse model of tuberculosis

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=127203

In vitro and in vivo activities of moxifloxacin and clinafloxacin against Mycobacterium tuberculosis.

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=127203

Pharmacokinetics, safety, and tolerability of ascending single doses of moxifloxacin, a new 8-methoxy quinolone, administered to healthy subjects

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=127203

Using therapeutic drug monitoring to dose the antimycobacterial drugs

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=127203

In vitro activity of BAY 12-8039, a new fluoroquinolone

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=127203

Statistics in practice. Comparing the means of several groups.

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=127203

Preclinical safety evaluation of moxifloxacin, a novel fluoroquinolone

5 July 2018

1 reference

12 December 2020

Absolute bioavailability of moxifloxacin

1 reference

12 December 2020

New tuberculosis drug development. How can we do better?

1 reference

12 December 2020

Pharmacokinetics and elimination of moxifloxacin after oral and intravenous administration in man

1 reference

12 December 2020

10.1128/AAC.46.6.1875-1879.2002

Identifiers

DOI

1 reference

31 July 2017

1 reference

31 July 2017

1 reference

PubMed ID

12019103